These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6065008)
1. What makes an adverse drug reaction study valid? McEvilla JD Hospitals; 1967 Sep; 41(17):114-8. PubMed ID: 6065008 [No Abstract] [Full Text] [Related]
2. [The work of the Adverse Effects Committee]. Borchgrevink CF Tidsskr Nor Laegeforen; 1987 Mar; 107(9):871-3. PubMed ID: 3590130 [No Abstract] [Full Text] [Related]
3. Preventability and severity assessment in reporting adverse drug reactions. Hartwig SC; Siegel J; Schneider PJ Am J Hosp Pharm; 1992 Sep; 49(9):2229-32. PubMed ID: 1524068 [No Abstract] [Full Text] [Related]
4. Drug administration times should be reexamined! Moggach BB Can Nurse; 1975 Jan; 71(1):17-9. PubMed ID: 1109304 [No Abstract] [Full Text] [Related]
5. [Control of adverse drug reaction in a hospital environment]. Honorato J; Giráldez J; Mart'i Mass'o R; Fos D; Velasco JL; S'anchez H Rev Med Univ Navarra; 1976; 20():209-11. PubMed ID: 1019512 [No Abstract] [Full Text] [Related]
6. An adverse drug reaction reporting program. Wasan SM; Marshall LB Can J Hosp Pharm; 1989 Dec; 42(6):239-41. PubMed ID: 10318356 [No Abstract] [Full Text] [Related]
7. [Safer drug handling in hospitals. A new task for the drug committee]. Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581 [No Abstract] [Full Text] [Related]
8. Most adverse drug events unreported: take these steps. Hosp Peer Rev; 2007 Oct; 32(10):143-5. PubMed ID: 17957885 [No Abstract] [Full Text] [Related]
10. [Create or strengthen the drug committee at a hospital]. Bruneton C Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023 [TBL] [Abstract][Full Text] [Related]
13. Pharmacy service: what are the goals of the pharmacy and therapeutics committee? Francke DE Hospitals; 1967 Oct; 41(20):99-100 passim. PubMed ID: 6065407 [No Abstract] [Full Text] [Related]
14. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Taras-Zasowski KM; Einarson TR Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271 [TBL] [Abstract][Full Text] [Related]
15. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
16. [The drug commission of German physicians and phase IV screening]. Ochsenfahrt H MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498 [No Abstract] [Full Text] [Related]
17. The acceptance of clinical pharmaceutical services. Lipman AG Hosp Formul; 1982 Jun; 17(6):783. PubMed ID: 10256039 [No Abstract] [Full Text] [Related]
18. [Drug committee at Ullevål hospital, Rikshospital, Ringerlike hospital, Trondheim region hospital. Work planning and practical experiences]. Gundersen G; Nordahl H; Jacobsen S; Lunde PK; Briseid AM; Flatberg P; Myhre E; Andersen R; Waago H Tidsskr Nor Laegeforen; 1975 Feb; 95(4):248-54. PubMed ID: 1129727 [No Abstract] [Full Text] [Related]
19. The Pharmacy and Therapeutics Committee Part 1: overview. Bender FH Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199 [TBL] [Abstract][Full Text] [Related]
20. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial. Dalton-Bunnow MF; Halvachs FJ Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]